Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,587 | -14,516 | -9,432 | -4,648 | -40,226 |
| Depreciation Amortization | 150 | 122 | 93 | 48 | 342 |
| Accounts payable and accrued liabilities | 55 | -52 | 407 | 314 | -430 |
| Other Working Capital | 688 | -1,236 | 976 | 644 | -1,339 |
| Other Operating Activity | 4,314 | 502 | -5 | -105 | 21,470 |
| Operating Cash Flow | $-19,380 | $-15,180 | $-7,961 | $-3,747 | $-20,183 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 40 | 86 | 36 | -8 | 385 |
| Purchase Of Investment | -46,637 | -26,488 | N/A | N/A | -503 |
| Sale Of Investment | 7,513 | 0 | N/A | N/A | 4,817 |
| Investing Cash Flow | $-39,084 | $-26,402 | $36 | $-8 | $4,699 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 68,428 | 51,463 | 52,964 | 14,165 | 13 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 13,433 |
| Financing Cash Flow | $68,428 | $51,463 | $52,964 | $14,165 | $13,446 |
| Beginning Cash Position | 4,259 | 4,259 | 4,259 | 4,259 | 6,297 |
| End Cash Position | 14,223 | 14,140 | 49,298 | 14,669 | 4,259 |
| Net Cash Flow | $9,964 | $9,881 | $45,039 | $10,410 | $-2,038 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,380 | -15,180 | -7,961 | -3,747 | -20,183 |
| Capital Expenditure | -64 | -18 | -18 | -8 | -6 |
| Free Cash Flow | -19,444 | -15,198 | -7,979 | -3,755 | -20,189 |